Scientists reveal a new mechanism that increases atherosclerosis in mice
Wednesday, November 4, 2009 - 15:56
in Health & Medicine
For all the good it does, a liver protein that senses and gets rid of drugs and pollutants from our body has a downside. For the first time, it has been shown that when it is chronically activated, the protein, called PXR, rejiggers how cholesterol is processed in the liver and increases the risk of developing atherosclerosis. The work has direct clinical consequences to patients under long-term treatment of PXR-activating drugs, including several antibiotic and anti-cancer medications — and your daily latte.
Read the whole article on The Rockefeller University
More from The Rockefeller University
Related
- Potential atherosclerosis drug exhibits no harmful side-effects in liverSat, 14 Feb 2009, 5:24:26 EST
- Long-term HIV treatment may reduce risk for atherosclerosisMon, 4 Aug 2008, 13:35:47 EDT
- Radiology procedure may help increase long-term survival in patients with severe liver cancerFri, 20 Nov 2009, 13:46:14 EST
- Medication does not appear to reduce progression of atherosclerosisTue, 17 Mar 2009, 17:58:54 EDT
- Prostaglandin receptor key to atherosclerosis developmentMon, 15 Dec 2008, 14:22:41 EST